nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—SOD1—amyotrophic lateral sclerosis	0.327	0.631	CbGaD
Oxaliplatin—GSTP1—amyotrophic lateral sclerosis	0.191	0.369	CbGaD
Oxaliplatin—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.159	0.428	CbGbCtD
Oxaliplatin—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.147	0.395	CbGbCtD
Oxaliplatin—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.0657	0.177	CbGbCtD
Oxaliplatin—SLC22A3—tongue—amyotrophic lateral sclerosis	0.00113	0.0354	CbGeAlD
Oxaliplatin—CA4—nerve—amyotrophic lateral sclerosis	0.00103	0.0323	CbGeAlD
Oxaliplatin—MT2A—spinal cord—amyotrophic lateral sclerosis	0.000803	0.025	CbGeAlD
Oxaliplatin—ATP7A—medulla oblongata—amyotrophic lateral sclerosis	0.000779	0.0243	CbGeAlD
Oxaliplatin—CA4—hindbrain—amyotrophic lateral sclerosis	0.000775	0.0242	CbGeAlD
Oxaliplatin—MT1A—cerebellum—amyotrophic lateral sclerosis	0.000764	0.0238	CbGeAlD
Oxaliplatin—ATP7B—nervous system—amyotrophic lateral sclerosis	0.000727	0.0227	CbGeAlD
Oxaliplatin—ATP7B—central nervous system—amyotrophic lateral sclerosis	0.0007	0.0218	CbGeAlD
Oxaliplatin—ATP7A—spinal cord—amyotrophic lateral sclerosis	0.000695	0.0217	CbGeAlD
Oxaliplatin—ATP7B—cerebellum—amyotrophic lateral sclerosis	0.000685	0.0213	CbGeAlD
Oxaliplatin—SOD1—medulla oblongata—amyotrophic lateral sclerosis	0.000682	0.0213	CbGeAlD
Oxaliplatin—MT2A—nervous system—amyotrophic lateral sclerosis	0.000676	0.0211	CbGeAlD
Oxaliplatin—SLC31A1—medulla oblongata—amyotrophic lateral sclerosis	0.000665	0.0207	CbGeAlD
Oxaliplatin—GSTT1—nervous system—amyotrophic lateral sclerosis	0.000662	0.0206	CbGeAlD
Oxaliplatin—MT2A—central nervous system—amyotrophic lateral sclerosis	0.000651	0.0203	CbGeAlD
Oxaliplatin—GSTP1—embryo—amyotrophic lateral sclerosis	0.000636	0.0198	CbGeAlD
Oxaliplatin—MT1A—brain—amyotrophic lateral sclerosis	0.000621	0.0193	CbGeAlD
Oxaliplatin—SOD1—spinal cord—amyotrophic lateral sclerosis	0.000608	0.019	CbGeAlD
Oxaliplatin—SLC31A1—spinal cord—amyotrophic lateral sclerosis	0.000593	0.0185	CbGeAlD
Oxaliplatin—ATP7B—brain—amyotrophic lateral sclerosis	0.000556	0.0173	CbGeAlD
Oxaliplatin—SLC22A3—embryo—amyotrophic lateral sclerosis	0.000544	0.017	CbGeAlD
Oxaliplatin—MT2A—brain—amyotrophic lateral sclerosis	0.000517	0.0161	CbGeAlD
Oxaliplatin—SLC31A1—nervous system—amyotrophic lateral sclerosis	0.000499	0.0156	CbGeAlD
Oxaliplatin—GSTM1—nervous system—amyotrophic lateral sclerosis	0.000487	0.0152	CbGeAlD
Oxaliplatin—SOD1—cerebellum—amyotrophic lateral sclerosis	0.000482	0.015	CbGeAlD
Oxaliplatin—SLC31A1—central nervous system—amyotrophic lateral sclerosis	0.000481	0.015	CbGeAlD
Oxaliplatin—SLC31A1—cerebellum—amyotrophic lateral sclerosis	0.00047	0.0147	CbGeAlD
Oxaliplatin—GSTM1—central nervous system—amyotrophic lateral sclerosis	0.000469	0.0146	CbGeAlD
Oxaliplatin—GSTM1—cerebellum—amyotrophic lateral sclerosis	0.000459	0.0143	CbGeAlD
Oxaliplatin—NQO1—medulla oblongata—amyotrophic lateral sclerosis	0.000455	0.0142	CbGeAlD
Oxaliplatin—ATP7A—brain—amyotrophic lateral sclerosis	0.000448	0.014	CbGeAlD
Oxaliplatin—CA4—brainstem—amyotrophic lateral sclerosis	0.000444	0.0138	CbGeAlD
Oxaliplatin—GSTP1—medulla oblongata—amyotrophic lateral sclerosis	0.000406	0.0127	CbGeAlD
Oxaliplatin—NQO1—spinal cord—amyotrophic lateral sclerosis	0.000405	0.0126	CbGeAlD
Oxaliplatin—SOD1—brain—amyotrophic lateral sclerosis	0.000392	0.0122	CbGeAlD
Oxaliplatin—SLC31A1—brain—amyotrophic lateral sclerosis	0.000382	0.0119	CbGeAlD
Oxaliplatin—MPO—spinal cord—amyotrophic lateral sclerosis	0.000373	0.0116	CbGeAlD
Oxaliplatin—GSTM1—brain—amyotrophic lateral sclerosis	0.000373	0.0116	CbGeAlD
Oxaliplatin—GSTP1—spinal cord—amyotrophic lateral sclerosis	0.000362	0.0113	CbGeAlD
Oxaliplatin—NQO1—nervous system—amyotrophic lateral sclerosis	0.000342	0.0107	CbGeAlD
Oxaliplatin—NQO1—central nervous system—amyotrophic lateral sclerosis	0.000329	0.0103	CbGeAlD
Oxaliplatin—NQO1—cerebellum—amyotrophic lateral sclerosis	0.000322	0.01	CbGeAlD
Oxaliplatin—MPO—nervous system—amyotrophic lateral sclerosis	0.000314	0.00979	CbGeAlD
Oxaliplatin—CA4—medulla oblongata—amyotrophic lateral sclerosis	0.00031	0.00966	CbGeAlD
Oxaliplatin—GSTP1—nervous system—amyotrophic lateral sclerosis	0.000305	0.00952	CbGeAlD
Oxaliplatin—MPO—central nervous system—amyotrophic lateral sclerosis	0.000302	0.00943	CbGeAlD
Oxaliplatin—GSTP1—central nervous system—amyotrophic lateral sclerosis	0.000294	0.00917	CbGeAlD
Oxaliplatin—GSTP1—cerebellum—amyotrophic lateral sclerosis	0.000287	0.00896	CbGeAlD
Oxaliplatin—CA4—spinal cord—amyotrophic lateral sclerosis	0.000276	0.00861	CbGeAlD
Oxaliplatin—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.000273	0.00852	CbGeAlD
Oxaliplatin—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.000263	0.0082	CbGeAlD
Oxaliplatin—NQO1—brain—amyotrophic lateral sclerosis	0.000261	0.00814	CbGeAlD
Oxaliplatin—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.000261	0.00814	CbGeAlD
Oxaliplatin—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.000251	0.00784	CbGeAlD
Oxaliplatin—MPO—brain—amyotrophic lateral sclerosis	0.00024	0.00749	CbGeAlD
Oxaliplatin—CYP1B1—nervous system—amyotrophic lateral sclerosis	0.00024	0.00748	CbGeAlD
Oxaliplatin—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000238	0.00741	CbGeAlD
Oxaliplatin—GSTP1—brain—amyotrophic lateral sclerosis	0.000233	0.00728	CbGeAlD
Oxaliplatin—CA4—nervous system—amyotrophic lateral sclerosis	0.000233	0.00725	CbGeAlD
Oxaliplatin—CYP1B1—central nervous system—amyotrophic lateral sclerosis	0.000231	0.0072	CbGeAlD
Oxaliplatin—CYP1B1—cerebellum—amyotrophic lateral sclerosis	0.000226	0.00704	CbGeAlD
Oxaliplatin—CA4—central nervous system—amyotrophic lateral sclerosis	0.000224	0.00698	CbGeAlD
Oxaliplatin—CA4—cerebellum—amyotrophic lateral sclerosis	0.000219	0.00683	CbGeAlD
Oxaliplatin—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000212	0.00661	CbGeAlD
Oxaliplatin—SLC22A1—brain—amyotrophic lateral sclerosis	0.000209	0.00651	CbGeAlD
Oxaliplatin—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000206	0.00642	CbGeAlD
Oxaliplatin—SLC22A3—brain—amyotrophic lateral sclerosis	0.0002	0.00622	CbGeAlD
Oxaliplatin—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000184	0.00572	CbGeAlD
Oxaliplatin—CYP1B1—brain—amyotrophic lateral sclerosis	0.000183	0.00572	CbGeAlD
Oxaliplatin—CA4—brain—amyotrophic lateral sclerosis	0.000178	0.00555	CbGeAlD
Oxaliplatin—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.00017	0.00529	CbGeAlD
Oxaliplatin—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000168	0.00524	CbGeAlD
Oxaliplatin—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000163	0.00509	CbGeAlD
Oxaliplatin—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000155	0.00482	CbGeAlD
Oxaliplatin—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000149	0.00464	CbGeAlD
Oxaliplatin—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000146	0.00454	CbGeAlD
Oxaliplatin—ABCG2—brain—amyotrophic lateral sclerosis	0.000137	0.00426	CbGeAlD
Oxaliplatin—CYP1A1—brain—amyotrophic lateral sclerosis	0.00013	0.00404	CbGeAlD
Oxaliplatin—CYP2E1—brain—amyotrophic lateral sclerosis	0.000118	0.00369	CbGeAlD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.62e-05	0.000846	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—FIG4—amyotrophic lateral sclerosis	6.57e-05	0.00084	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	6.54e-05	0.000836	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.53e-05	0.000834	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	6.44e-05	0.000823	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	6.37e-05	0.000814	CbGpPWpGaD
Oxaliplatin—SLC22A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	6.35e-05	0.000812	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.3e-05	0.000805	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	6.24e-05	0.000798	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	6.21e-05	0.000794	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.14e-05	0.000784	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	6.02e-05	0.00077	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	6e-05	0.000767	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.97e-05	0.000763	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—DAO—amyotrophic lateral sclerosis	5.94e-05	0.000759	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	5.94e-05	0.000759	CbGpPWpGaD
Oxaliplatin—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	5.94e-05	0.000759	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	5.89e-05	0.000753	CbGpPWpGaD
Oxaliplatin—SLC22A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	5.79e-05	0.000741	CbGpPWpGaD
Oxaliplatin—ABCC2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	5.74e-05	0.000734	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—DAO—amyotrophic lateral sclerosis	5.69e-05	0.000728	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	5.67e-05	0.000725	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	5.64e-05	0.000721	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—DAO—amyotrophic lateral sclerosis	5.55e-05	0.000709	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.52e-05	0.000706	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	5.49e-05	0.000702	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	5.48e-05	0.0007	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	5.48e-05	0.0007	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	5.43e-05	0.000694	CbGpPWpGaD
Oxaliplatin—SLC22A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	5.4e-05	0.00069	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	5.37e-05	0.000687	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—VAPB—amyotrophic lateral sclerosis	5.29e-05	0.000677	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—TPK1—amyotrophic lateral sclerosis	5.29e-05	0.000677	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—SQSTM1—amyotrophic lateral sclerosis	5.2e-05	0.000665	CbGpPWpGaD
Oxaliplatin—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	5.16e-05	0.00066	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	5.1e-05	0.000652	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	5.1e-05	0.000652	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.1e-05	0.000652	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—PLB1—amyotrophic lateral sclerosis	5.08e-05	0.000649	CbGpPWpGaD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	5.06e-05	0.000647	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	5.01e-05	0.00064	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	4.88e-05	0.000624	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—ATF1—amyotrophic lateral sclerosis	4.88e-05	0.000624	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—VAPA—amyotrophic lateral sclerosis	4.84e-05	0.000619	CbGpPWpGaD
Oxaliplatin—CYP1B1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.81e-05	0.000615	CbGpPWpGaD
Oxaliplatin—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	4.81e-05	0.000615	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.75e-05	0.000607	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.69e-05	0.0006	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.69e-05	0.0006	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—GSR—amyotrophic lateral sclerosis	4.68e-05	0.000599	CbGpPWpGaD
Oxaliplatin—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.67e-05	0.000596	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.66e-05	0.000596	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CASP9—amyotrophic lateral sclerosis	4.65e-05	0.000594	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	4.57e-05	0.000584	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	4.55e-05	0.000581	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.54e-05	0.00058	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.5e-05	0.000575	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.5e-05	0.000575	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	4.41e-05	0.000564	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.34e-05	0.000554	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.32e-05	0.000552	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	4.28e-05	0.000547	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—FIG4—amyotrophic lateral sclerosis	4.23e-05	0.000541	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.22e-05	0.00054	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.21e-05	0.000538	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.18e-05	0.000535	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—GSR—amyotrophic lateral sclerosis	4.15e-05	0.000531	CbGpPWpGaD
Oxaliplatin—CYP1A1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.13e-05	0.000527	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.08e-05	0.000521	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.02e-05	0.000514	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—GSR—amyotrophic lateral sclerosis	3.98e-05	0.000509	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—ERBB4—amyotrophic lateral sclerosis	3.98e-05	0.000508	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	3.93e-05	0.000503	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—GSR—amyotrophic lateral sclerosis	3.88e-05	0.000496	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.85e-05	0.000492	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.84e-05	0.000491	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—DAO—amyotrophic lateral sclerosis	3.83e-05	0.000489	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD40LG—amyotrophic lateral sclerosis	3.74e-05	0.000478	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.69e-05	0.000471	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.69e-05	0.000471	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.5e-05	0.000447	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.47e-05	0.000444	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.46e-05	0.000443	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.44e-05	0.00044	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.42e-05	0.000437	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.42e-05	0.000437	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	3.41e-05	0.000436	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.41e-05	0.000436	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.37e-05	0.000431	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.36e-05	0.000429	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.36e-05	0.000429	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.32e-05	0.000424	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.32e-05	0.000424	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—C3—amyotrophic lateral sclerosis	3.3e-05	0.000422	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.27e-05	0.000418	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.25e-05	0.000416	CbGpPWpGaD
Oxaliplatin—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	3.23e-05	0.000413	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.23e-05	0.000413	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.21e-05	0.00041	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.19e-05	0.000407	CbGpPWpGaD
Oxaliplatin—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.14e-05	0.000402	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.14e-05	0.000401	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.1e-05	0.000397	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.1e-05	0.000396	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.09e-05	0.000396	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.09e-05	0.000396	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.07e-05	0.000392	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.05e-05	0.00039	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.04e-05	0.000388	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	2.98e-05	0.000381	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.97e-05	0.00038	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.97e-05	0.00038	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.97e-05	0.00038	CbGpPWpGaD
Oxaliplatin—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.96e-05	0.000379	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.95e-05	0.000377	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.95e-05	0.000377	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.94e-05	0.000376	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.94e-05	0.000376	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.92e-05	0.000374	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—PLB1—amyotrophic lateral sclerosis	2.9e-05	0.000371	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.85e-05	0.000365	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.83e-05	0.000362	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.82e-05	0.000361	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	2.81e-05	0.000359	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.79e-05	0.000357	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.76e-05	0.000353	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.74e-05	0.000351	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.74e-05	0.000351	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.68e-05	0.000343	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—GSR—amyotrophic lateral sclerosis	2.68e-05	0.000342	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—DAO—amyotrophic lateral sclerosis	2.67e-05	0.000341	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.65e-05	0.000339	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.65e-05	0.000339	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.63e-05	0.000336	CbGpPWpGaD
Oxaliplatin—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.63e-05	0.000336	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.62e-05	0.000335	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.6e-05	0.000332	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	2.58e-05	0.00033	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.47e-05	0.000316	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.45e-05	0.000313	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	2.43e-05	0.00031	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—APOE—amyotrophic lateral sclerosis	2.43e-05	0.00031	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.41e-05	0.000308	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.41e-05	0.000308	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.4e-05	0.000307	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.27e-05	0.00029	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.27e-05	0.00029	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	2.25e-05	0.000288	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.24e-05	0.000286	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.22e-05	0.000283	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.2e-05	0.000282	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—CHAT—amyotrophic lateral sclerosis	2.2e-05	0.000281	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.12e-05	0.000271	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.08e-05	0.000266	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.07e-05	0.000264	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.05e-05	0.000262	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.03e-05	0.000259	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.02e-05	0.000258	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.93e-05	0.000247	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.93e-05	0.000246	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.9e-05	0.000243	CbGpPWpGaD
Oxaliplatin—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.89e-05	0.000242	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—GSR—amyotrophic lateral sclerosis	1.86e-05	0.000238	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.86e-05	0.000238	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.84e-05	0.000235	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.83e-05	0.000234	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.82e-05	0.000233	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.82e-05	0.000232	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.78e-05	0.000228	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	1.74e-05	0.000223	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.71e-05	0.000219	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.7e-05	0.000217	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.7e-05	0.000217	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.7e-05	0.000217	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.68e-05	0.000215	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.68e-05	0.000215	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.66e-05	0.000212	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.64e-05	0.00021	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000207	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.57e-05	0.000201	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.56e-05	0.0002	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—APOE—amyotrophic lateral sclerosis	1.56e-05	0.0002	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—TP53—amyotrophic lateral sclerosis	1.53e-05	0.000196	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.53e-05	0.000196	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.45e-05	0.000185	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.45e-05	0.000185	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.4e-05	0.000179	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.39e-05	0.000178	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—APOE—amyotrophic lateral sclerosis	1.39e-05	0.000177	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.38e-05	0.000176	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.35e-05	0.000173	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—APOE—amyotrophic lateral sclerosis	1.33e-05	0.00017	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.32e-05	0.000169	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.32e-05	0.000169	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—APOE—amyotrophic lateral sclerosis	1.3e-05	0.000166	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.29e-05	0.000164	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.24e-05	0.000159	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.23e-05	0.000157	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.22e-05	0.000156	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.18e-05	0.000151	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.16e-05	0.000148	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.15e-05	0.000147	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000139	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.07e-05	0.000137	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.05e-05	0.000134	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.05e-05	0.000134	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1e-05	0.000128	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.57e-06	0.000122	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.5e-06	0.000121	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.43e-06	0.000121	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.11e-06	0.000116	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	8.93e-06	0.000114	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.87e-06	0.000113	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.61e-06	0.00011	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.23e-06	0.000105	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	7.93e-06	0.000101	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.56e-06	9.67e-05	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.49e-06	9.57e-05	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.41e-06	9.47e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	7.32e-06	9.36e-05	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.91e-06	8.83e-05	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.88e-06	8.8e-05	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.81e-06	8.71e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.67e-06	8.52e-05	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.35e-06	8.11e-05	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—APOE—amyotrophic lateral sclerosis	6.22e-06	7.96e-05	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.12e-06	7.82e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.01e-06	7.69e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.9e-06	7.54e-05	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	5.66e-06	7.24e-05	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	5.6e-06	7.16e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.49e-06	7.01e-05	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.38e-06	6.87e-05	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.22e-06	6.68e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.07e-06	6.48e-05	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.94e-06	6.32e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.66e-06	5.95e-05	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.26e-06	5.45e-05	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	4.06e-06	5.2e-05	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.88e-06	4.96e-05	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.84e-06	4.91e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.83e-06	4.9e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.76e-06	4.81e-05	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.58e-06	4.57e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.23e-06	4.13e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.97e-06	3.8e-05	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.79e-06	3.56e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.63e-06	3.36e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.44e-06	3.12e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.67e-06	2.14e-05	CbGpPWpGaD
